A detailed history of Nissay Asset Management Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Nissay Asset Management Corp holds 52,205 shares of AZN stock, worth $3.36 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
52,205
Previous 44,011 18.62%
Holding current value
$3.36 Million
Previous $3.43 Million 18.5%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $628,233 - $717,958
8,194 Added 18.62%
52,205 $4.07 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $707,183 - $855,585
10,585 Added 31.67%
44,011 $3.43 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $1.44 Million - $1.64 Million
23,590 Added 239.83%
33,426 $2.26 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $311,430 - $348,616
5,032 Added 104.75%
9,836 $662,000
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $311,539 - $344,446
4,804 New
4,804 $325,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.